NasdaqGS - Nasdaq Real Time Price USD
Pulmonx Corporation (LUNG)
3.3700
-0.2700
(-7.42%)
At close: May 9 at 4:00:01 PM EDT
3.5300
+0.16
+(4.75%)
After hours: May 9 at 7:53:23 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | -0.39 | -0.39 | -1.54 | -1.39 |
| Low Estimate | -0.42 | -0.42 | -1.59 | -1.55 |
| High Estimate | -0.35 | -0.37 | -1.49 | -1.18 |
| Year Ago EPS | -0.35 | -0.36 | -1.44 | -1.54 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 7 | 7 |
| Avg. Estimate | 23.46M | 23.77M | 97.02M | 114.52M |
| Low Estimate | 23.28M | 23.3M | 96M | 110.4M |
| High Estimate | 23.8M | 24.25M | 97.47M | 118.25M |
| Year Ago Sales | 20.78M | 20.39M | 83.79M | 97.02M |
| Sales Growth (year/est) | 12.89% | 16.60% | 15.79% | 18.04% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.43 | -0.44 | -0.45 | -0.4 |
| EPS Actual | -0.35 | -0.36 | -0.33 | -0.36 |
| Difference | 0.08 | 0.08 | 0.12 | 0.04 |
| Surprise % | 17.79% | 18.83% | 26.49% | 9.97% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.39 | -0.39 | -1.54 | -1.39 |
| 7 Days Ago | -0.39 | -0.38 | -1.55 | -1.41 |
| 30 Days Ago | -0.39 | -0.38 | -1.55 | -1.41 |
| 60 Days Ago | -0.39 | -0.38 | -1.54 | -1.43 |
| 90 Days Ago | -0.4 | -0.38 | -1.58 | -1.3 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | -- |
| Up Last 30 Days | 2 | 1 | 2 | 3 |
| Down Last 7 Days | 2 | 4 | 2 | 1 |
| Down Last 30 Days | 2 | 4 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| LUNG | -12.82% | -9.30% | -6.92% | 9.60% |
| S&P 500 | 12.66% | 3.22% | 7.99% | 13.82% |
Upgrades & Downgrades
| Maintains | Canaccord Genuity: Buy to Buy | 5/1/2025 |
| Reiterates | Piper Sandler: Overweight to Overweight | 5/1/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 5/1/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 3/11/2025 |
| Initiated | D. Boral Capital: Buy | 3/10/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 12/11/2024 |
Related Tickers
SIBN SI-BONE, Inc.
18.49
+0.87%
VREX Varex Imaging Corporation
6.88
-20.46%
CVRX CVRx, Inc.
4.7700
-38.69%
TMCI Treace Medical Concepts, Inc.
6.82
-9.55%
KIDS OrthoPediatrics Corp.
22.04
-4.51%
QTRX Quanterix Corporation
5.28
-4.17%
OFIX Orthofix Medical Inc.
12.11
-1.62%
OM Outset Medical, Inc.
15.30
-3.65%
AXGN Axogen, Inc.
11.37
-9.73%
IART Integra LifeSciences Holdings Corporation
12.25
-4.97%